Michael Ackermann $TARS SEC Form 4 Insider Trading

Michael Ackermann has filed a total of 16 insider trades in $TARS since 2021. Their most recent trade was a purchase of 100,000 shares, made on May 05, 2022. Their largest trade was a purchase of 100,000 shares, made on May 05, 2022. We estimate that they now own 1.3 million shares of $TARS, worth an estimated $52.9 million.

Insider Trading at $TARS

There have been a total of 197 insider trades reported at $TARS since 2021, with 128,906 shares purchased and 1.5 million shares sold. The most active insider traders in $TARS stock have been Bobak R. Azamian, Bobak R. Azamian, and Aziz Mottiwala. The most recent trade was a sale of 13,608 shares reported by Jeffrey S Farrow (See Remarks), made on Jun 17, 2025.

$TARS Executives and Stock Owners with Insider Trades

• Bobak R. Azamian, President/CEO and Board Chair

• Bobak R. Azamian, President and CEO

• Aziz Mottiwala, Chief Commercial Officer

• Leonard M. Greenstein, Chief Financial Officer

• Bryan Wahl, General Counsel

• Dianne C. Whitfield, Chief Human Resources Officer

• Seshadri Neervannan, Chief Operating Officer

• Jose M. Trevejo, CHIEF MEDICAL OFFICER

• Jeffrey S Farrow, See Remarks

• Mark J. Holdbrook, V.P., Clinical Affairs

• Elizabeth Yeu Lin, Chief Medical Officer

• Jose M. Trevejo, Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.